$GNLX 3 SEC Filings

Filed On	Filing
07 Jan 2026	Form 3: Litten Jason, Chief Medical Officer No securities owned
02 Jul 2025	Form 3: Groen Eric, General Counsel & Secretary No securities owned
03 Feb 2025	Form 3: Pulisic Matthew, Chief Financial Officer No securities owned
13 Sep 2023	Form 3: Smither John W, Director Holds 900 shares of Common Stock
30 Aug 2023	Form 3: Zak Lourie S., Chief Financial Officer No securities owned
03 Jul 2023	Form 3: Smalling Ralph, Head of Regulatory Holds 3,000 shares of Common Stock
03 Jul 2023	Form 3: Jewett Caroline, Head of Quality Holds 1,650 shares of Common Stock
25 Jan 2023	Form 3: Szalay Aladar, 10% owner Holds 32,167 shares of Common Stock
25 Jan 2023	Form 3: Mirabelli Mary, Director
25 Jan 2023	Form 3: Woodward Gabe, Director
25 Jan 2023	Form 3: Tyree James L, Director
25 Jan 2023	Form 3: Thomas John, Director
25 Jan 2023	Form 3: Ryder Sean, General Counsel
25 Jan 2023	Form 3: Samuelson Doug, Chief Financial Officer
25 Jan 2023	Form 3: Scigalla Paul, Chief Medical Officer
25 Jan 2023	Form 3: Cappello Joseph, VP, Pharmaceutical Development
25 Jan 2023	Form 3: Yu Tony, VP, Clinical Trial Operations Holds 150,000 shares of Common Stock
25 Jan 2023	Form 3: Zhang Qian, Associate VP, Research Holds 133,333 shares of Common Stock
25 Jan 2023	Form 3: Zindrick Thomas, Director

Comments